drug acts potent selective agonist subtype neural nicotinic acetylcholine receptors high level brain penetration good oral bioavailability development possible treatment cognitive deficits reduces protects striatal dopaminergic neurons rat also potentiates cognitive enhancement decreases dynorphin inhibits